Beovu (brolucizumab) is used to treat patients with wet age-related macular degeneration (AMD), a chronic eye disorder. AMD is the leading cause of vision loss for people 50 years and older and it may cause a person to struggle reading fine print and have dark vision...
![Beovu Vision Loss Lawsuit](https://inserra.com/wp-content/uploads/2021/01/blogimg.jpg)